Precision therapy for ulcerative colitis: insights from mitochondrial dysfunction interacting with the immune microenvironment
What other mechanisms may promote weight loss, and what factors would allow these agents to potentially compete with GLP-1 and GLP-1/GIP receptor agonists
(2020) 13(1):dmm042655 doi: 10.1242/dmm.042655
Overall, while there is a robust theoretical and biochemical framework supporting the exploration of PYY analogs as a therapy for conditions like PWS, there is a need for more direct evidence from clinical trials to substantiate the use of PYY analogs as an effective treatment
In others, promising findings from animal studies are driving new clinical investigations
Calibrate physicians conduct more intensive monitoring with regular lab work, body composition analysis, and detailed metabolic assessments every 3-6 months